Cenobamate – Medxy AI

Cenobamateは局在発作型の難治性・超難治性重積発作に有効か ― 多施設コホート研究とマッチ解析

Cenobamate in Focal-Onset Refractory and Super-Refractory Status Epilepticus: A Multicenter Cohort Study With Matched Analysis

By MedXY 11/07/2026

This multicenter study shows cenobamate is effective and safe as adjunctive therapy for refractory focal-onset status epilepticus, improving seizure control and outcomes.

Neurology news

Superior Efficacy of Cenobamate in Drug-Resistant Focal Epilepsy: Real-World Evidence

By MedXY 04/29/2026

This article reviews a large real-world study demonstrating cenobamate's superior effectiveness over brivaracetam, lacosamide, and perampanel in reducing seizures for adults with drug-resistant focal epilepsy.

Neurology news

Cenobamate Outperforms Brivaracetam, Lacosamide, and Perampanel in Real-World Focal Epilepsy Management

By MedXY 02/10/2026

A large multicenter real-world study indicates that cenobamate provides superior effectiveness and seizure freedom rates compared to brivaracetam, lacosamide, and perampanel in adults with drug-resistant focal epilepsy, despite a higher incidence of adverse effects.